Specialty Pharmacy Is No Longer Optional Infrastructure
The organizations that move now — with the right foundation and the right partners —…
Specialty Pharmacy Is No Longer Optional Infrastructure
The organizations that move now — with the right foundation and the right partners — will enter the next planning cycle with a specialty pharmacy that functions as a true strategic asset. The post Specialty Pharmacy Is No Longer Optional Infrastructure appeared first on MedCity News.
Brain Interfaces Don’t Need Surgery to Be Transformative – and the Distinction Is Now a Strategic One
Non-surgical implantable BCI is increasingly capable of matching surgical performance while transforming the risk-benefit equation, and it is now the most credible path along all three dimensions simultaneously. The post Brain Interfaces Don’t Need Surgery to Be Transformative – and the Distinction Is Now a Strategic One appeared first on MedCity News.
New KFF Poll Examines Patterns of Belief Across Common Vaccine Myths — The Monitor
KFF’s latest Tracking Poll on Health Information and Trust shows that larger shares of the public express uncertainty over common vaccine myths than definitive belief. The latest analysis shows which adults are consistent myth believers, consistent myth deniers, and those who fall in the “mixed middle.”
My Search for a Psychiatric Bed in an Overburdened Health System
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.” Eight days before my 33rd birthday in April, a social worker at a crisis clinic near Denver determined I was an imminent danger to myself. She placed me on an…
MGB Nurses, Home Health Staff Launch Strike Over Wages, Benefits
More than 4,000 Brigham and Women’s Hospital nurses and 450 home health workers launched Massachusetts’ largest-ever healthcare strike this week over stalled contract talks on wages and benefits. The strike quickly prompted Governor Maura Healey to step in and convene both sides at the State House, but it remains unclear whether a deal is near….
Vera Therapeutics’ First-in-Class Kidney Disease Drug Lands Speedy FDA Approval
FDA approval of Vera Therapeutics’ Trutakna makes it first in a new class of medicines designed to block two targets to treat immunoglobulin A nephropathy, an autoimmune disease that can progress to end-stage renal failure. Competition looms from Vertex Pharmaceuticals, on track to receive a November regulatory decision for a drug designed to block the…
Pearl Health Lands $110M to Support Value-Based Care for Medicare Patients
Pearl’s $110 million raise includes a $50 million equity investment led by Andreessen Horowitz with participation from Viking Global Investors, AlleyCorp and Ulysses Capital, as well as a $60 million debt facility led by Trinity Capital. The post Pearl Health Lands $110M to Support Value-Based Care for Medicare Patients appeared first on MedCity News.
Organ-on-a-chip, Organoids, but Drug Testing on Whole Organs? This Startup is Betting On It
Many startups and established companies focused on drug testing on human data in preclinical studies have been boosted by FDA’s move away from reliance on animal testing towards organoid, organ-on-a-chip, and other in silico technologies. A Connecticut startup believes whole-organ testing should be an essential part of this mix. The post Organ-on-a-chip, Organoids, but Drug…
What Can Payers Do to Improve AI Readiness?
[Sponsored] A webinar by Verato and MedCity News on July 22 will explore how building a trusted data foundation that connects the healthcare ecosystem can improve how payers deploy AI. The post What Can Payers Do to Improve AI Readiness? appeared first on MedCity News.
Financial Impact of Treatment Choice in Chronic Myeloid Leukemia
That is the title of a recent paper out in ClinicoEconomics and Outcomes Research with co-authors Jennifer Vaughn, Nadine Zawadzki, Shurui Zhang, Paul Pinkston, and David Wei. The subtitle is A Comparison of Later Generation TKIs versus Imatinib from Patient and Payer Perspectives. The abstract is below: Purpose: To evaluate the financial impact of treating CML…
